198 related articles for article (PubMed ID: 32179814)
1. Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process.
González-González A; González A; Rueda N; Alonso-González C; Menéndez JM; Martínez-Campa C; Mitola S; Cos S
Sci Rep; 2020 Mar; 10(1):4790. PubMed ID: 32179814
[TBL] [Abstract][Full Text] [Related]
2. Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process.
González-González A; González A; Rueda N; Alonso-González C; Menéndez-Menéndez J; Gómez-Arozamena J; Martínez-Campa C; Cos S
Front Physiol; 2019; 10():879. PubMed ID: 31354524
[TBL] [Abstract][Full Text] [Related]
3. Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts.
González-González A; García Nieto E; González A; Sánchez-Fernández C; Alonso-González C; Menéndez-Menéndez J; Gómez-Arozamena J; Cos S; Martínez-Campa C
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412584
[TBL] [Abstract][Full Text] [Related]
4. Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells.
González-González A; González A; Alonso-González C; Menéndez-Menéndez J; Martínez-Campa C; Cos S
Oncol Rep; 2018 Jan; 39(1):433-441. PubMed ID: 29115538
[TBL] [Abstract][Full Text] [Related]
5. Effect of melatonin on EGF- and VEGF-induced monolayer permeability of HUVECs.
Yang L; Zhang Y; Ma Y; Du J; Gu L; Zheng L; Zhang X
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1178-H1191. PubMed ID: 30575440
[TBL] [Abstract][Full Text] [Related]
6. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression.
Cui P; Yu M; Peng X; Dong L; Yang Z
J Pineal Res; 2012 Mar; 52(2):236-43. PubMed ID: 21913973
[TBL] [Abstract][Full Text] [Related]
7. Development of in vitro and in vivo tools to evaluate the antiangiogenic potential of melatonin to neutralize the angiogenic effects of VEGF and breast cancer cells: CAM assay and 3D endothelial cell spheroids.
Laborda-Illanes A; Sánchez-Alcoholado L; Castellano-Castillo D; Boutriq S; Plaza-Andrades I; Aranega-Martín L; Peralta-Linero J; Alba E; González-González A; Queipo-Ortuño MI
Biomed Pharmacother; 2023 Jan; 157():114041. PubMed ID: 36423543
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds.
Cerezo AB; Hornedo-Ortega R; Álvarez-Fernández MA; Troncoso AM; García-Parrilla MC
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28282869
[TBL] [Abstract][Full Text] [Related]
9. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
10. Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
J Pineal Res; 2013 May; 54(4):373-80. PubMed ID: 23013414
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines.
Jardim-Perassi BV; Lourenço MR; Doho GM; Grígolo IH; Gelaleti GB; Ferreira LC; Borin TF; Moschetta MG; Pires de Campos Zuccari DA
Anticancer Agents Med Chem; 2016; 16(3):347-58. PubMed ID: 25963143
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
15. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
16. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro.
Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J
Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effects of melatonin in endothelial cell cultures.
Alvarez-García V; González A; Alonso-González C; Martínez-Campa C; Cos S
Microvasc Res; 2013 May; 87():25-33. PubMed ID: 23473980
[TBL] [Abstract][Full Text] [Related]
18. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
19. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
20. Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.
González A; González-González A; Alonso-González C; Menéndez-Menéndez J; Martínez-Campa C; Cos S
Oncol Rep; 2017 Apr; 37(4):2433-2440. PubMed ID: 28259965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
